Pioglitazone Completed Phase N/A Trials for Insulin Resistance / Cardiovascular Heart Disease / HIV Lipodystrophy / Human Immunodeficiency Virus (HIV) Infections / The Metabolic Syndrome Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnosticNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00656851Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome